China has approved a new obesity treatment from Pfizer, heightening competition in a market poised to become even more crowded ...

PHILADELPHIA -- Pfizer and BioNTech said Tuesday they have submitted Covid-19 vaccine data on children ages 5 to 11 to the US Food and Drug Administration for initial review, but are not yet seeking ...

Feb 3(Reuters) - Pfizer on Tuesday said an experimental obesity drug acquired through its $10 billion Metsera purchase showed sustained weight loss at 28 weeks as a monthly injection, and the U.S.

Feb 3(Reuters) - Pfizer on Tuesday released trial data on a high-profile obesity drug from its recent $10 billion Metsera purchase that raises questions about its tolerability for patients, and shares ...

Pfizer ( PFE) said its Phase 2 study of tilrekimig (PF-07275315), a trispecific antibody for atopic dermatitis, showed ...

Pfizer (PFE)-backed Priovant Therapeutics wins U.S. FDA's priority review for skin disorder therapy with a targeted action ...